Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1996 Jun;74(6):497–501. doi: 10.1136/adc.74.6.497

Osteocalcin, growth, and inhaled corticosteroids: a prospective study.

I Doull 1, N Freezer 1, S Holgate 1
PMCID: PMC1511559  PMID: 8758124

Abstract

OBJECTIVES: To determine the relationship between biochemical markers of bone metabolism and statural growth, and their suitability as surrogate markers of inhaled corticosteroid induced growth suppression. DESIGN: Randomised, double blind, placebo controlled comparison of inhaled beclomethasone dipropionate 200 micrograms twice daily as dry powder for six months. SETTING: Southampton. OUTCOME MEASURES: Serum osteocalcin, urinary deoxypyridinoline, and statural growth. SUBJECTS: 7 to 9 year old children with recurrent wheeze. RESULTS: There were no significant differences in serum osteocalcin between the beclomethasone dipropionate and placebo group measured at baseline or after three and six months' treatment, while deoxy-pyridinoline was significantly higher in the placebo treated children after three months. Growth was significantly decreased in the beclomethasone dipropionate group over the course of the study. Growth over the six months, both in those receiving beclomethasone dipropionate and those receiving placebo, was significantly correlated with serum osteocalcin measured at three months and six months. CONCLUSION: Although serum osteocalcin shows excellent correlation with growth, it is a poor marker for decreased growth associated with use of inhaled corticosteroids.

Full text

PDF
497

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adinoff A. D., Hollister J. R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983 Aug 4;309(5):265–268. doi: 10.1056/NEJM198308043090502. [DOI] [PubMed] [Google Scholar]
  2. Cole D. E., Carpenter T. O., Gundberg C. M. Serum osteocalcin concentrations in children with metabolic bone disease. J Pediatr. 1985 May;106(5):770–776. doi: 10.1016/s0022-3476(85)80351-6. [DOI] [PubMed] [Google Scholar]
  3. Delmas P. D. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med. 1991 Nov 25;91(5B):59S–63S. doi: 10.1016/0002-9343(91)90250-2. [DOI] [PubMed] [Google Scholar]
  4. Delmas P. D., Chatelain P., Malaval L., Bonne G. Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res. 1986 Aug;1(4):333–338. doi: 10.1002/jbmr.5650010406. [DOI] [PubMed] [Google Scholar]
  5. Delmas P. D., Schlemmer A., Gineyts E., Riis B., Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res. 1991 Jun;6(6):639–644. doi: 10.1002/jbmr.5650060615. [DOI] [PubMed] [Google Scholar]
  6. Doull I. J., Freezer N. J., Holgate S. T. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med. 1995 Jun;151(6):1715–1719. doi: 10.1164/ajrccm.151.6.7767512. [DOI] [PubMed] [Google Scholar]
  7. Hodsman A. B., Toogood J. H., Jennings B., Fraher L. J., Baskerville J. C. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab. 1991 Mar;72(3):530–540. doi: 10.1210/jcem-72-3-530. [DOI] [PubMed] [Google Scholar]
  8. Johansen J. S., Jensen S. B., Riis B. J., Rasmussen L., Zachmann M., Christiansen C. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab. 1990 Jul;71(1):122–126. doi: 10.1210/jcem-71-1-122. [DOI] [PubMed] [Google Scholar]
  9. Kanzaki S., Hosoda K., Moriwake T., Tanaka H., Kubo T., Inoue M., Higuchi J., Yamaji T., Seino Y. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab. 1992 Oct;75(4):1104–1109. doi: 10.1210/jcem.75.4.1400878. [DOI] [PubMed] [Google Scholar]
  10. König P., Hillman L., Cervantes C., Levine C., Maloney C., Douglass B., Johnson L., Allen S. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr. 1993 Feb;122(2):219–226. doi: 10.1016/s0022-3476(06)80116-2. [DOI] [PubMed] [Google Scholar]
  11. Littlewood J. M., Johnson A. W., Edwards P. A., Littlewood A. E. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet. 1988 Jan 16;1(8577):115–116. doi: 10.1016/s0140-6736(88)90310-8. [DOI] [PubMed] [Google Scholar]
  12. Pouw E. M., Prummel M. F., Oosting H., Roos C. M., Endert E. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ. 1991 Mar 16;302(6777):627–628. doi: 10.1136/bmj.302.6777.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Price P. A., Otsuka A. A., Poser J. W., Kristaponis J., Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A. 1976 May;73(5):1447–1451. doi: 10.1073/pnas.73.5.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rüegsegger P., Medici T. C., Anliker M. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol. 1983;25(5):615–620. doi: 10.1007/BF00542348. [DOI] [PubMed] [Google Scholar]
  15. Sorva R., Turpeinen M., Juntunen-Backman K., Karonen S. L., Sorva A. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol. 1992 Nov;90(5):808–815. doi: 10.1016/0091-6749(92)90106-c. [DOI] [PubMed] [Google Scholar]
  16. Spock A. Growth patterns in 200 children with bronchial asthma. Ann Allergy. 1965 Dec;23(12):608–615. [PubMed] [Google Scholar]
  17. Teelucksingh S., Padfield P. L., Tibi L., Gough K. J., Holt P. R. Inhaled corticosteroids, bone formation, and osteocalcin. Lancet. 1991 Jul 6;338(8758):60–61. doi: 10.1016/0140-6736(91)90058-w. [DOI] [PubMed] [Google Scholar]
  18. Thomsen K., Eriksen E. F., Jørgensen J. C., Charles P., Mosekilde L. Seasonal variation of serum bone GLA protein. Scand J Clin Lab Invest. 1989 Nov;49(7):605–611. doi: 10.1080/00365518909091535. [DOI] [PubMed] [Google Scholar]
  19. Toogood J. H., Jennings B., Hodsman A. B., Baskerville J., Fraher L. J. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol. 1991 Oct;88(4):572–580. doi: 10.1016/0091-6749(91)90150-m. [DOI] [PubMed] [Google Scholar]
  20. Voss L. D., Bailey B. J., Cumming K., Wilkin T. J., Betts P. R. The reliability of height measurement (the Wessex Growth Study). Arch Dis Child. 1990 Dec;65(12):1340–1344. doi: 10.1136/adc.65.12.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wolthers O. D., Riis B. J., Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol. 1993 Dec;16(6):341–346. doi: 10.1002/ppul.1950160604. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES